Novartis to file for Pluvicto label expansion
Novartis said it will file for a label expansion with the U.S. Food and Drug Administration (FDA) later this year to expand the use of its Pluvicto radiopharmaceutical drug to patients with earlier cases of prostate cancer.
Currently, Pluvictro (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) is indicated in adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer who have previously received other anticancer therapies. The new filing follows additional data from the phase III PSMAfore study that demonstrates favorable overall survival (OS)...
Source: AuntMinnie.com Headlines - April 8, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
After life-changing losses, these millennials are now trying to help others preserve their loved ones' legacy
It wasn't until he became a father that Nicholas Worley rekindled the idea of preserving memories of his loved ones and their legacies. That idea first germinated when Worley was just 16. He lost his paternal grandfather to prostate cancer and his maternal grandmother to Alzheimer's that same year…#nicholasworley #britishcolombian #inalife #hongkong #singaporean #hareshtilani #terencechia #whartonschool #singapore #singaporeans (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
New Prostate Cancer Cases May More Than Double To 2.9 Million By 2040
The Lancet Commission report warned that much more needs to be done urgently to address this continuing prostate cancer surge. Otherwise global deaths will rise rapidly. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 7, 2024 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening
(MedPage Today) -- A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI detected one additional high-grade cancer per 196 men and one low-grade cancer per 909 men, according... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 6, 2024 Category: Hematology Source Type: news
Cheaper, quicker prostate cancer scans just as accurate ‘and can help more men’
Groundbreaking research finds dropping the third stage of standard MRI test for the disease doesn ’t hamper detection rates, and cuts costs in halfCutting the duration ofMRI scans for prostate cancer by a third would make them cheaper and more accessible without reducing their accuracy. That is the key result of a UK trial which indicates that lowering costs could ensure more men are offered scans.According to Cancer Research UK, there are about 52,300 new prostate cancer cases every year in the UK, equal to more than 140 a day.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 6, 2024 Category: Science Authors: Robin McKie Science editor Tags: Prostate cancer Science Health UK news Source Type: news
Prostate cancer test fails to detect some aggressive forms, study shows
UK research highlights risk of over-diagnosis and gaps in spotting serious variants of the disease (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 6, 2024 Category: Pharmaceuticals Source Type: news
Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis
The largest study to date investigating a single invitation to a PSA blood test* to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. The CAP trial, published in the Journal of the American Medical Association (JAMA) and carried out by researchers from the universities of Bristol, Oxford and Cambridge, involved over 400,000 men aged 50-69. Just under half received a single invitation for a PSA test as part of the trial. (Source: University of Bristol news)
Source: University of Bristol news - April 6, 2024 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
Faster, cheaper scan for prostate cancer on the way as experts say new test could mean thousands more men are tested every year
Experts predict it will change clinical practice, catching more cases early and paving the way for thousands more men to be tested each year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2024 Category: Consumer Health News Source Type: news
Bracing for a Surge in Prostate Cancer Diagnoses
(MedPage Today) -- Driven by increased life expectancy and related changes in age structure, global prostate cancer cases will more than double over the next 15 years, a panel of experts concluded.
The number of new cases will increase from 1... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 5, 2024 Category: American Health Source Type: news
Integration of MRI Screening Beneficial for Prostate Cancer
FRIDAY, April 5, 2024 -- Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
Number of Prostate Cancer Cases Set to Increase to 2.9 Million in 2040
FRIDAY, April 5, 2024 -- The number of new prostate cancer cases is set to increase to 2.9 million in 2040, according to a study published online April 4 in The Lancet.
Nicholas D. James, M.B.B.S., Ph.D., from the Institute of Cancer Research in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
